<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00930748</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-08-4965-OP-CTIL</org_study_id>
    <nct_id>NCT00930748</nct_id>
  </id_info>
  <brief_title>Evaluation of MRI for Prostate Cancer</brief_title>
  <official_title>Evaluation of the Potential of Endorectal MRI for the Staging and Recurrence of Prostate Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate imaging quality and correlation with
      histopathology in prostate cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to evaluate of the potential of endorectal 3T MRI for the
      staging of prostate cancer before prostatectomy or recurrence of prostate cancer after
      prostatectomy
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The MRI company forbidded additional scans with endorectal colil in this machine
  </why_stopped>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>â€¢ MRI and pathology correlation</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Prostatic Neoplasms</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MR imaging with endorectal coil</intervention_name>
    <description>MR imaging with endorectal coil</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI with endo-rectal coil</intervention_name>
    <description>MRI with endo-rectal coil</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with prostate cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age of patients: up to 80 years.

          -  Men scheduled for radical prostatectomy due to prostate cancer or men post radical
             prostatectomy with suspicion of recurrence.

          -  Patients who are able and willing to give consent and able to have an MRI examination.

        Exclusion Criteria:

          -  Contraindications to MRI including: claustrophobia, weight over 120 kg, implanted
             ferromagnetic materials or foreign objects, and known intolerance to the MRI contrast
             agent (e.g. Gadolinium or Dotarem)

          -  Individuals who are not able or willing to tolerate the required prolonged stationary
             supine position during imaging (approximately 1 hr.)

          -  Any rectal pathology preventing probe insertion, (as active proctitis, active
             ulcerative colitis, fissure ani)

          -  Any spinal pathology that prohibits maintaining supine position for an hour

          -  Patients with documented myocardial infarction within one month of protocol entry, and
             patients with cardiac pacemakers

          -  Severe cerebrovascular disease (multiple CVA or CVA within 6 months)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2009</study_first_submitted>
  <study_first_submitted_qc>June 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2009</study_first_posted>
  <last_update_submitted>June 24, 2011</last_update_submitted>
  <last_update_submitted_qc>June 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Orith Portnoy</name_title>
    <organization>Sheba Medical Center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

